Evidence of Risk GLP-1 agonists have become a popular choice for patients who are looking to lose weight and/or have type 2 diabetes
Se necesitan ensayos clnicos rigurosos, a gran escala y a largo plazo para establecer definitivamente la eficacia, seguridad y papel apropiado de los medicamentos GLP-1 en el tratamiento del trastorno de atracones
They are not for human or animal consumption, and are not intended to diagnose, treat, cure, or prevent any disease
This does not mean higher doses are unsafe or that you should avoid escalation
Batch-to-Batch Consistency Ensures reproducibility and quality across manufacturing lots
Instead of hitting personal records on heavy lifts or running at race pace, shift to steady-state cardio (walking, cycling at conversational pace) and moderate-weight resistance training